Apis Capital Advisors LLC Takes Position in Syndax Pharmaceuticals, Inc. $SNDX

Apis Capital Advisors LLC purchased a new position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 638,000 shares of the company's stock, valued at approximately $9,816,000. Syndax Pharmaceuticals comprises 2.2% of Apis Capital